This topic contains a solution. Click here to go to the answer

Author Question: Compare and contrast the light silicate minerals and dark silicate minerals, and give examples of ... (Read 149 times)

Tazate

  • Hero Member
  • *****
  • Posts: 532
Compare and contrast the light silicate minerals and dark silicate minerals, and give examples of each.
 
  What will be an ideal response?

Question 2

Japan has the world's ________ largest economy.
 
  A) second
  B) third
  C) tenth
  D) fifteenth



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

epscape

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

Answer: Both are silicate minerals, dominated by the elements silicon and oxygen, arranged in the silicon-oxygen tetrahedron. Light silicates tend to have larger amounts of sharing between their silicon-oxygen tetrahedral, while dark silicates tend to have less sharing (more oxygen atoms for every atom of silicon. Light silicates tend to include sodium and potassium in their crystal structure, while dark silicates tend to include magnesium, iron, or calcium.

Answer to Question 2

B




Tazate

  • Member
  • Posts: 532
Reply 2 on: Jul 14, 2018
Gracias!


ktidd

  • Member
  • Posts: 319
Reply 3 on: Yesterday
Excellent

 

Did you know?

Cucumber slices relieve headaches by tightening blood vessels, reducing blood flow to the area, and relieving pressure.

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library